Universal Corporation (NYSE: UVV) — Form 10-K Summary
Period clarification: The request labels the period “2022 Q4,” but the supplied filing is Universal Corporation’s Form 10-K for the fiscal year ended March 31, 2024, with comparisons to fiscal 2023 and fiscal 2022.
Business context and reporting period
Universal is a global business-to-business agriproducts company operating in more than 30 countries. Its two segments are Tobacco Operations, which procures and processes leaf tobacco, and Ingredients Operations, which produces plant-based food and beverage ingredients. Fiscal 2024 was described as an exceptional year for tobacco and a significant investment-building year for ingredients.
Financial results and liquidity
| Metric | FY2024 | FY2023 | Change |
|---|---|---|---|
| Revenue | $2,748.6 million | $2,569.8 million | Up 7% |
| Gross margin | 19.50% | 17.83% | Up 167 basis points |
| Operating income, reported | $222.0 million | $181.1 million | Up 23% |
| Adjusted operating income, non-GAAP | $230.3 million | $181.1 million | Up 27% |
| Net income attributable to Universal | $119.6 million | $124.1 million | Down 4% |
| Diluted EPS, reported | $4.78 | $4.97 | Down 4% |
| Adjusted diluted EPS, non-GAAP | $5.08 | $3.77 | Up 35% |
| Interest expense | $66.3 million | $49.3 million | Up $17.0 million |
| Cash used in operating activities | $74.6 million | $10.6 million | Greater cash use |
| Capital expenditures | $66.0 million | $54.7 million | Up $11.3 million |
Revenue growth reflected higher tobacco selling prices and a more favorable product mix, partly offset by lower tobacco volumes. Tobacco Operations revenue was $2,438.8 million and operating income was $222.4 million, up 8% and 29%, respectively. Ingredients Operations revenue was $309.8 million, down 1%, while operating income fell to $3.9 million from $10.6 million.
Reported parent-attributable net income and EPS declined despite higher operating income, in part because FY2023 included a $24.2 million net Brazilian tax benefit and $5.0 million of related interest income. The effective tax rate was 19.0% in FY2024 versus 8.3% in FY2023; excluding the FY2023 Brazil tax ruling and other specified items, management said the FY2023 rate would have been about 25.5%.
Cash and cash equivalents were $55.6 million at March 31, 2024. Working capital was approximately $1.4 billion. Tobacco inventory was $1.07 billion, up $236.7 million year over year, largely due to accelerated Brazilian purchases and higher green-leaf prices. Operating cash use increased primarily because of this working-capital build.
Net debt, as defined by the company, increased $245.4 million to $996.2 million; net debt was approximately 41% of net capitalization, versus 35% a year earlier. Long-term debt was $617.4 million and notes payable and overdrafts were $417.2 million. The company reported $405 million available under its committed revolving facility and approximately $135 million available under uncommitted lines. It was in compliance with debt covenants and said it had adequate resources for at least the next 12 months.
Material changes versus the prior comparable period
- Tobacco results improved on favorable product mix, stronger customer demand, larger African crops, and higher selling prices; lower volumes partly offset the gains.
- Ingredients earnings weakened due to infrastructure and capability-building costs, inventory write-downs, lower raw-material prices, and customer inventory recalibrations. New product sales partly offset these pressures.
- Interest expense rose with higher interest rates. The company used swaps to fix rates on $310 million of term-loan principal.
- Operating cash flow turned more negative as accelerated tobacco buying in Brazil increased inventory and financing needs.
Outlook, management commentary, risks, and unusual items
- Management described tobacco supply as tight, with elevated green-leaf prices and low industry uncommitted inventories, and expects supply and demand to rebalance over time. It said the working-capital impact of accelerated buying should mostly unwind over the next two years.
- Management expects to spend approximately $55 million to $65 million on capital expenditures in FY2025. The Lancaster ingredients facility expansion was expected to be operational in the second half of FY2025 and to contribute meaningfully to Ingredients Operations results in FY2026. No specific consolidated earnings or revenue guidance is provided in the supplied filing text.
- FY2024 reported results included $4.8 million of costs from a Brazilian value-added tax settlement program and $3.5 million of restructuring and impairment costs. Management excluded these items in its adjusted non-GAAP measures.
- A separate Paraná VAT assessment in Brazil had a stated range of reasonably possible loss of zero to approximately $3 million; management considered no loss probable and recorded no liability. The filing says other litigation and tax matters are not currently expected to materially affect the business or financial position, though an adverse resolution could materially affect a particular period.
- Key risks include customer concentration (the six largest tobacco customers represented about 60% of consolidated revenue; Philip Morris International and Imperial Brands each exceeded 10% in FY2024), tobacco demand and regulatory changes, crop quality and weather, inflation and supply-chain disruption, foreign exchange and interest-rate exposure, farmer advances, and food safety and supply concentration risks in ingredients.
- The company reported no cybersecurity incident to date that had a material or reasonably likely material impact. Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls and internal controls were effective.
Important facts for investors to verify
- Whether accelerated tobacco purchases convert to customer shipments and cash collection as expected, and whether uncommitted tobacco inventory declines.
- Whether tight tobacco supply and elevated green-leaf prices persist, and how price, volume, and product mix affect tobacco margins.
- Whether Ingredients Operations recovers earnings as new products grow, customer inventories normalize, and the Lancaster expansion reaches operation on schedule.
- How higher interest costs and seasonal borrowing affect cash flow, net debt, and covenant headroom.
- Developments in tobacco regulation and customer demand, including the exposure created by reliance on a small number of large customers.
- Recovery and valuation of farmer advances and VAT credits, and the outcome of the unresolved Paraná assessment.